In the BioHarmony Drug Report Database

"Preview" Icon

Sodium oxybate

Xyrem (sodium oxybate) is a small molecule pharmaceutical. Sodium oxybate was first approved as Xyrem on 2002-07-17. It is used to treat cataplexy in the USA. It has been approved in Europe to treat cataplexy and narcolepsy. It is known to target hydroxycarboxylic acid receptor 1. Xyrem’s patents are valid until 2033-03-15 (FDA).

 

Trade Name

 

Xyrem
 

Common Name

 

sodium oxybate
 

ChEMBL ID

 

CHEMBL1200682
 

Indication

 

cataplexy, narcolepsy
 

Drug Class

 

Image (chem structure or protein)

Sodium oxybate structure rendering